ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2937

Regulation of Follicular Helper T (TFH) Cells By ROCK2 (Rho-associated coiled-coil containing protein kinase 2)

Woelsung Yi1, Sanjay Gupta2, Chien-Huan Weng3, Yurii Chinenov4, James K. Liao5 and Alessandra B. Pernis6, 1Hospital for Special Surgery, New York, NY, 2Autoimmunity & Inflammation Research Program, Hospital for Special Surgery, New York, NY, 3Weill Cornell Medical College, New York, NY, 4Arthritis & Tissue Degeneration Program, Hospital for Special Surgery, New York, NY, 5Cardiology Section, University of Chicago Medical Center, Chicago, IL, 6David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: anti-dsDNA, immune tolerance and plasma cells, SLE, T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 15, 2016

Title: T Cell Biology and Targets in Autoimmune Disease - Poster Session II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Follicular helper T (TFH) cells promote humoral responses and serve as a limiting factor for the selection of high affinity germinal center B cells. TFH cell numbers need to be tightly regulated, and TFH cell expansion has been associated with autoimmune diseases including SLE. Rho-associated kinases (ROCKs), ROCK1 and ROCK2, are major downstream effectors of the small GTPase RhoA. The ROCKs regulate both gene expression and cytoskeletal reorganization. Increased ROCK activation has been observed in autoimmune disease both in mice and humans, and ROCK inhibition ameliorates autoimmunity in murine models. However, the underlying molecular and cellular mechanisms by which the ROCKs affect autoimmune disease are currently unknown. Here we investigated the role of ROCK2 in TFH cell expansion under physiological conditions and in autoimmunity by employing mice lacking DEF6 and SWAP-70, which exhibit aberrant ROCK activation, accumulation of TFH cells, and spontaneously develop a lupus-like disease.

Methods: Mice lacking ROCK2 in T cells were generated by crossing CD4cre mice with ROCK2flox/flox mice. The TFH cell compartment was assessed in CD4creROCK2flox/flox mice by immunizing with a T-dependent antigen. To evaluate the effect of T-cell ROCK2 on autoimmune disease CD4creROCK2flox/flox mice were crossed with Def6trap/trapSwap-70-/- mice (DKO mice), which develop a lupus-like disease primarily in females. Flow cytometry analysis and ELISAs were used to assess TFH cell expansion and autoantibody production.

Results: The absence of ROCK2 in T cells did not lead to any abnormality in the frequencies or activation state of the T cell compartment at baseline. Lack of T cell ROCK2, however, resulted in a significant decrease in TFH cell formation upon immunization with a T-dependent antigen. This was associated with a reduction in germinal center B cell and plasma cell formation suggesting that T-cell ROCK2 is essential for T-dependent immune responses. To evaluate the contribution of T-cell ROCK2 to TFH cell formation in autoimmunity, we analyzed CD4creROCK2flox/flox Def6trap/trapSwap-70-/- mice (ROCK2ΔT DKO) mice. Upon deletion of T cell ROCK2, the spontaneous increase in TFH cells observed in DKO mice was significantly reduced. This was associated with decreased GC B cells, plasma cell numbers, and diminished anti-dsDNA autoantibody levels.

Conclusion: Our current study indicates that ROCK2 regulates TFH cells both during T-dependent immune responses as well as in autoimmune settings further supporting a role for ROCK inhibition as a potential treatment for SLE and other autoimmune diseases that exhibit dysregulation in TFH cells.


Disclosure: W. Yi, None; S. Gupta, None; C. H. Weng, None; Y. Chinenov, None; J. K. Liao, None; A. B. Pernis, Investigator-initiated grant from Kadmon Corporation, 2.

To cite this abstract in AMA style:

Yi W, Gupta S, Weng CH, Chinenov Y, Liao JK, Pernis AB. Regulation of Follicular Helper T (TFH) Cells By ROCK2 (Rho-associated coiled-coil containing protein kinase 2) [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/regulation-of-follicular-helper-t-tfh-cells-by-rock2-rho-associated-coiled-coil-containing-protein-kinase-2/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/regulation-of-follicular-helper-t-tfh-cells-by-rock2-rho-associated-coiled-coil-containing-protein-kinase-2/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology